Glaxosmithkline | Driftsresultat



Operating Profit Lave om Dato
AbbVie USD 3.73B 5.22B 2025-03
Amgen USD 2.31B 182M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bausch Health Companies USD 276M 332M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Indivior 66M 226M 2025-03
J&J USD 13.63B 9.74B 2025-03
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pacira USD 24.7M 164.23M 2024-12
Perrigo USD 112.7M 37.4M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Prestige Brands USD 91.96M 7.62M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Takeda JPY 66.94B 117.3B 2024-12
Teva Pharmaceutical Industries USD 455M 506M 2024-12
Zoetis USD 732M 142M 2024-12



Glaxosmithkline Driftsresultat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.